SYK
Stryker Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 172 | +2 | 222.54M | $70.41B | +7 | −4 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | — | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | — |
| Q2 2024 | 16 | — | 41.27M | $14.03B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 11.70M | — | $3.98B | 0.5% | n/c | 1 | SEC ↗ ×2 |
| 2 | Wellington Management ✦ | 11.24M | — | $3.82B | 0.7% | n/c | 1 | SEC ↗ ×8 |
| 3 | Geode Capital Management ✦ (passive) | 6.74M | — | $2.29B | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 5.00M | — | $1.70B | 0.3% | n/c | 1 | SEC ↗ |
| 5 | Fisher Asset Management ✦ | 4.28M | — | $1.46B | 0.6% | n/c | 1 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 447.50K | — | $152.26M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 375.30K | — | $127.70M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 325.20K | — | $110.65M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 324.94K | — | $110.56M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 306.80K | — | $104.39M | 0.5% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 232.64K | — | $79.16M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 125.33K | — | $42.49M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 13 | Marshall Wace ✦ | 122.20K | — | $41.58M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 14 | Millennium Management ✦ | 33.32K | — | $11.34M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | GAMCO Investors ✦ | 14.19K | — | $4.83M | 0.1% | n/c | 1 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 1.25K | — | $424,632 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,274 holders, 283.44M shares, $87.41B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 18 sh @ 225.19 · $4,054
Director · 3 sh @ 185.65 · $557
Director · 36 sh @ 193.21 · $6,956
Director · 11 sh @ 221.03 · $2,431
Director · 63 sh @ 202.21 · $12,739
Open-market sales (S)
Officer · 441 sh · $144,915
Director · 11.26K sh · $3.81M
Director · 40 sh · $13,272
Director · 440 sh · $146,598
Director · 200 sh · $66,786
Director · 80 sh · $26,804
Director · 320 sh · $107,774
Director · 2.31K sh · $780,062
Director · 10.81K sh · $3.67M
Director · 16.61K sh · $5.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology